Jean-Claude GUILLEMOT

Dernières Publications

1. Drugs against SARS-CoV-2: what do we know about their mode of action? (2020)
   Valle C, Martin B, Touret F, Shannon A, Canard B., Guillemot JC , Coutard B Decroly E.
   Rev Med Virol in press
2. Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. (2020)
   Shannon A, Tuyet Le NT, Selisko B, Eydoux C, Alvarez K, Guillemot JC , Decroly E, Peersen O, Ferron F, Canard B
   Antiviral Res in press 104793
3. Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay. (2019)
   Ferreira-Ramos AS, Li C, Eydoux C, Contreras JM, Morice C, Querat G, Gigante A, Perez Perez MJ, Jung ML, Canard B, Guillemot JC , Decroly E, Coutard B
   Antiviral Res 163 59-69
4. Hijacking DNA methyltransferase transition state analogues to produce chemical scaffolds for PRMT inhibitors. (2018)
   Halby L, Marechal N, Pechalrieu D, Cura V, Franchini DM, Faux C, Alby F, Troffer-Charlier N, Kudithipudi S, Jeltsch A, Aouadi W, Decroly E, Guillemot JC , Page P, Ferroud C, Bonnefond L, Guianvarc'h D, Cavarelli J, Arimondo PB
   Philos Trans R Soc Lond B Biol Sci 373
5. Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay. (2017)
   Aouadi W, Eydoux C, Coutard B, Martin B, Debart F, Vasseur JJ, Contreras JM, Morice C, Querat G, Jung ML, Canard B, Guillemot JC , Decroly E
   Antiviral Res 144 330-339